The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
28 Jun 2020	Submitted	Original manuscript
30 Jun 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
2 Jul 2020	Editorially accepted
14 Jul 2020	Article published	10.1186/s13063-020-04576-9

Back to article page